A new process to study the movements and vulnerabilities of circulating tumor cells responsible for cancer recurrence in patients with non-small cell lung cancer (NSCLC) has been discovered by researchers.
Non-small cell lung cancer (NSCLC) is a devastating disease and the leading cause of American cancer deaths. Even patients suitable for tumor removal have a 50% mortality rate.
The researchers took tumor fragments from ten human NSCLC patients and injected them into immunodeficient mice....
↧